May 2011 · Vol. 60, No. 05 Suppl
Clinical Conversations: Primary Care Management of Patients With Asthma
Stephen A. Brunton, MD, FAAFP (moderator)
Adjunct Clinical Professor, Department of Family Medicine, University of North Carolina, Chapel Hill, North CarolinaLeRoy M. Graham
Georgia Pediatric Pulmonary Associates, PC; Associate Clinical Professor of Pediatrics, Morehouse School of Medicine; Founder and Medical Director, Not One More Life, Inc, Atlanta, Georgia
LISTEN TO AUDIOCAST | TRANSCRIPT | DOWNLOAD THE SLIDES
Please review the required CME information below prior to accessing this CME audiocast.
After reviewing this activity, the learner will be better able to:
Assess asthma severity to initiate therapy and control to adjust therapy.
Describe the evolving evidence regarding small- and large-airway inflammation in asthma.
Identify appropriate clinical use of long-acting inhaled β-agonists (LABAs) and LABA combinations for the treatment of asthma in patients with persistent asthma.
Describe how better physician-patient communication and the use of a written asthma action plan (WAAP) can help improve patient self-management
Family physicians and clinicians who have an interest in treating patients with asthma.
As a continuing medical education provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Primary Care Education Consortium to require any individual in a position to influence educational content to disclose the existence of any financial interest or other personal relationship with the manufacturer(s) of any commercial product(s).
Dr. Brunton disclosed that he is on advisory boards for Amylin Pharmaceuticals, Boehringer-Ingelheim, Novo Nordisk, Sepracor, Sunovion, and Teva Pharmaceuticals and on speaker's bureaus for Boehringer-Ingelheim, Kowa Pharmaceuticals America, Novo Nordisk, and Teva Pharmaceuticals.
Dr. Graham disclosed that he is a member of speaker's bureaus and advisory boards for Merck & Co, Inc, and Teva Pharmaceuticals.
The Primary Care Education Consortium clinical staff have provided financial disclosure and have no conflicts of interest to resolve related to this activity.
The continuing medical education (CME) reviewer for this activity, Allan Wilke, MD, has no real or apparent conflicts of interest to report.
CONFLICT OF INTEREST
When individuals in a position to control content have reported financial relationships with one or more commercial interests, the Primary Care Education Consortium works with them to resolve such conflicts to ensure that the content presented is free of commercial bias. The content of this activity was vetted by the following mechanisms and modified as required to meet this standard:
In accordance with ACCME guidelines, the faculty authors have been asked to disclose discussion on unlabeled or unapproved uses of drugs or devices during the course of the activity.
The Primary Care Education Consortium is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been planned and implemented in accordance with the Essentials and Standards of the ACCME through the Primary Care Education Consortium.
The Primary Care Education Consortium designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Accreditation begins on May 1, 2011, and ends on May 1, 2012.
Audio with accompanying slide presentation.
This activity is sponsored by the Primary Care Education Consortium.
This activity is supported by an educational grant from Teva Pharmaceuticals.
METHOD OF PHYSICIAN PARTICIPATION
To receive CME credit, please listen to the audio and review the accompanying slides, and upon completion, go to: www.pceconsortium.org/asthmawebcast to complete the online evaluation to receive your certificate of completion.
Copyright © 2011 Quadrant HealthCom Inc. and the Primary Care Education Consortium